The Authors' Reply to "The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome"
- PMID: 30996197
- PMCID: PMC6746649
- DOI: 10.2169/internalmedicine.2793-19
The Authors' Reply to "The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome"
Keywords: Stenotrophomonas maltophilia; fluoroquinolone; immunosuppressive; sulfamethoxazole/trimethoprim.
Conflict of interest statement
Comment on
-
Fatal Neutropenic Enterocolitis Caused by Stenotrophomonas maltophilia: A Rare and Underrecognized Entity.Intern Med. 2018 Dec 15;57(24):3667-3671. doi: 10.2169/internalmedicine.1227-18. Epub 2018 Aug 10. Intern Med. 2018. PMID: 30101922 Free PMC article.
-
The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome.Intern Med. 2019 Aug 15;58(16):2419. doi: 10.2169/internalmedicine.2661-19. Epub 2019 Apr 17. Intern Med. 2019. PMID: 30996192 Free PMC article. No abstract available.
References
-
- Stern A, Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev CD005590, 2014. - PubMed
-
- Ko JH, Kang CI, Cornejo-Juarez P, et al. . Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. Clin Microbiol Infect 2018(Epub ahead of print). - PubMed